Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CTSO

CytoSorbents to Raise Funds Through Rights Offering, Unlocking Up to $10M in Liquidity

CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the details of its anticipated

Benzinga · Dec 9, 2024

Kyrgyzstan to host Russia-led defence bloc drills

Kyrgyzstan will host a Russia-led security bloc's peacekeeping drills this year instead of Armenia, which last month declined to host the exercise, the bloc's chief of staff said on Tuesday.

Reuters · Feb 14, 2023

Kremlin warns bid to join NATO by Finland, Sweden will not improve security

The Kremlin said Monday that the decisions by Finland and Sweden to join the NATO military alliance will not improve security in Europe. Meanwhile, Moscow held a meeting of the six-country Collective Security Treaty Organisation.

Radio France Internationale · May 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

CytoSorbents's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, CytoSorbents's (NASDAQ:CTSO) reported sales totaled $8.69 million. Despite a 3.66% increase in earnings, the company posted a loss of $8.97 million.

Benzinga · May 12, 2022

Recap: CytoSorbents Q1 Earnings

CytoSorbents (NASDAQ:CTSO) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings CytoSorbents missed estimated earnings by 75.0%, reporting an EPS of $-0.21 versus an estimate of $-0.12.

Benzinga · May 3, 2022

CytoSorbents: Q4 Earnings Insights

CytoSorbents (NASDAQ:CTSO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 8, 2022

CytoSorbents Earnings Preview

CytoSorbents (NASDAQ:CTSO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate that CytoSorbents will report an earnings per share (EPS) of $-0.13.

Benzinga · Mar 7, 2022

Read news from The Economist, FT, and more,
with one subscription

Love Putin, MAGA heads? Then join him!

A modest proposal: Chunks of Florida, Alabama and Mississippi can join Putin's faux-NATO group. It's a win-win!

Salon · Feb 16, 2022

CytoSorbents Expects Upside FY21 Sales, Despite COVID-19 Headwinds

CytoSorbents Corp (NASDAQ: CTSO) reported preliminary

Benzinga · Jan 18, 2022

Coverage From

People

Vladimir Putin

38,605 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.